Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023
15 Mai 2023 - 3:00PM
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia
management company focused on improving the way cardiac arrhythmias
are diagnosed and treated, is pleased to announce its participation
in the upcoming Heart Rhythm Society (HRS) Annual Scientific
Sessions in New Orleans, LA from May 19-21, 2023.
As an exhibitor at HRS, Acutus Medical will showcase its latest
groundbreaking electrophysiology systems and technologies,
including AcQMap®, the industry's only whole-chamber, single-beat,
non-contact mapping system. Designed to help physicians advance the
standard of care for patients with complex arrhythmias, AcQMap
equips electrophysiologists with an unprecedented ability to map
what was historically unmappable.
“We are pleased to join HRS ’23 to offer the industry an
opportunity to engage directly with our state-of-the-art cardiac
mapping and ablation therapy technologies, as well as meet with
many of our key physician partners,” said David Roman, President
& CEO of Acutus Medical. “The recently published RECOVER AF
study is driving important discussions around the pivotal advantage
AcQMap® offers physicians in the retreatment of AF. HRS provides an
ideal forum to provide deeper insight into the study’s findings and
further demonstrate AcQMap’s significant clinical benefits.”
Visitors to the Acutus Medical booth (#923) will have the
opportunity to join Dr. Timothy Betts, Clinical Lead for Cardiac
Electrophysiology at Oxford University Hospitals and Principal
Investigator of RECOVER AF, for an in-booth presentation on the
study’s results, as well as participate in peer-to-peer discussions
about its findings and their impact on AF retreatment strategies.
In addition to Dr. Betts’ presentation, Acutus Medical is hosting a
wide variety of events, including a range of peer-to-peer
presentations from leading cardiac electrophysiologists and current
Acutus users, live demonstrations and case reviews, and
physician-led discussions. A full schedule of planned activities
can be found here.
Furthermore, several physicians will also present their most
recent AcQMap research. Notable highlights include Dr. Dhanunjaya
Lakkireddy, Executive Director of the Kansas City Heart Rhythm
Institute at HCA Midwest, Overland Park presenting new findings on
the use of the AcQMap system for trigger mapping, titled
“Non-Pulmonary Vein Triggers and Associated Pathological Substrate:
Inroads into the Less Understood Science of Non-Paroxysmal Atrial
Fibrillation Therapeutic Targets with a Novel Non-Contact Mapping
System,” at the HRS Late Breaking Science Poster Session, as well
as Dr. Simon James, Consultant Electrophysiologist, South Tees
Hospitals NHS Trust, and Dr. Alexander Sharp, Clinical Research
Fellow, John Radcliffe Hospital, who will deliver presentations
during the Ablation Sessions.
“As a pioneer in the field of electrophysiology, Acutus Medical
delivers cutting-edge tools that provide critical information
conventional mapping systems cannot, which helps physicians deliver
personalized therapy for atrial arrhythmias,” said Shibaji Shome,
Ph.D., Vice President of Marketing at Acutus Medical. “As a premier
global event, #HRS2023 is a critical opportunity to showcase the
impact AcQMap, as well as the entire Acutus portfolio, has on the
daily practice of electrophysiologists and foster fellowship among
our user community to drive future investigations into the powerful
benefits of non-contact mapping.”
About Acutus MedicalAcutus Medical (“Acutus” or
the “Company”) is an arrhythmia management company focused on
improving the way cardiac arrhythmias are diagnosed and treated.
Acutus is committed to advancing the field of electrophysiology
with a unique portfolio of technologies and solutions designed to
enable physicians to treat more patients more effectively. Through
internal product development, acquisitions, and global
partnerships, Acutus has established a global sales presence that
delivers targeted electrophysiology solutions for the
catheter-based treatment of cardiac arrhythmias. Founded in 2011,
Acutus is based in Carlsbad, California.
Follow Acutus Medical on: Twitter, LinkedIn,
and YouTube
Investor ContactCaroline Corner
415-202-5678caroline.corner@westwicke.com
Media ContactRhiannon
Pickus442-232-6094Rhiannon.Pickus@acutus.com
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
Von Mai 2023 bis Mai 2024